Stocks
The Healing Company Inc.HLCO
PNKHealthcareBiotechnology$0.00
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing psychedelic-assisted therapies for mental health conditions, including PTSD and depression. Its pipeline focuses on natural psilocybin and other compounds, with early-stage trials underway. Investors track HLCO for its exposure to the emerging psychedelics therapeutics market.
52W Range: $0.00-$0.00
Congressional Interest in The Healing Company Inc. (HLCO)
1 member of Congress has disclosed 1 trade in The Healing Company Inc. (HLCO), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading HLCO?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2014-07-24 | JOHN K. DELANEY | buy | $1K-$15K |